Articles From: Galena Biopharma Provides 2015 Outlook to Game of Thrones® IMAX® Screenings Rescheduled One Week Later To Accommodate Unprecedented Fan Enthusiasm


PORTLAND, Ore., Jan.
Sign-up for Galena Biopharma Provides 2015 Outlook investment picks
- Allowed claims will cover the use of NeuVax alone or in combination to prevent recurrence of any breast cancer tumor expressing low-to-intermediate levels of HER2 - Extends patent coverage to three main markets, U.S., EU and now Japan PORTLAND, Ore., Oct.
Sign-up for Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan investment picks
Clinical programs advance on multiple fronts, with trial initiation, trial enrollment, data and IP milestones achieved and anticipated Commercial strategy reinforced with product acquisition and upcoming commercial launch Abstral ® (fentanyl) sublingual tablet net revenue was $1.6 million in Q3 2014 and $6.1 million to date this year, with reiterated guidance of $8-$10 million for the full year 2014 Zuplenz ® (ondansetron) Oral Soluble Film U.S. rights licensed; launch expected in Q1 2015 Conference call scheduled for 5:00 pm E.T. today with details below PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Reports Third Quarter 2014 Results investment picks
PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference investment picks
PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma to Present at the Stifel 2014 Healthcare Conference investment picks
BEDFORD, Texas , Dec.
Sign-up for Galenfeha Asset Tracking System Marks Another Field Success investment picks
BEDFORD, Texas , Nov.
Sign-up for Galenfeha Asset Tracking System Proves Successful investment picks
TEL AVIV, Israel , Jan.
Sign-up for Galmed Pharmaceuticals Announces the Appointment of Josh Blacher as Chief Financial Officer investment picks
-- Results Confirm Favorable Safety Profile of Two High Doses of Aramchol --
Sign-up for Galmed Pharmaceuticals Completes Analysis of a Pharmacokinetic Study of Aramchol in Healthy Volunteers investment picks
2014/11/12
-- Conference Call and Webcast Today at 8:30 a.m. EST/5:30 a.m. PST --
Sign-up for Galmed Pharmaceuticals Provides Business Update and Reports Year-To-Date 2014 Financial Results investment picks
TEL AVIV, Israel , Jan.
Sign-up for Galmed Pharmaceuticals to Present at the Biotech Showcase™ investment picks
http://media.marketwire.com/attachments/201410/286837_Galtronicslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154835&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Galtronics Antennas Enable Improved Mobile Connectivity at the Sydney Cricket Ground (SCG) investment picks
Galtronics' LTE, DAS & Small Cell Antennas Are Now Available Canada NewsWire With 4.1/9.5 Mini-DIN Connectors TORONTO , Jan.
Sign-up for Galtronics' LTE, DAS & Small Cell Antennas Are Now Available investment picks
With 4.1/9.5 Mini-DIN Connectors TORONTO , Jan.
Sign-up for Galtronics' LTE, DAS & Small Cell Antennas Are Now Available investment picks
2014/11/3
Continuation Remote Operating License Given to Gamblit Gaming to Function in Alderney LOS ANGELES , Nov.
Sign-up for Gamblit Gaming Is Granted United Kingdom Gambling Commission Approval investment picks
GAMCO Investors, Inc. (NYSE:GBL) announced today that its Board of Directors declared a special dividend of $0.25 per share in addition to increasing its quarterly dividend by 17% to $0.07 per share to all of its Class A and Class B shareholders, payable on December 30, 2014 to its shareholders of record on December 16, 2014.
Sign-up for GAMCO Board Increases Quarterly Dividend by 17% to $0.07 Per Share and Declares a Special Dividend of $0.25 Per Share investment picks
GAMCO Investors, Inc. (“GAMCO”) (NYSE:GBL) today reported its 2014 third quarter results including revenues of $110.9 million, net income of $23.7 million and earnings of $0.93 per diluted share.
Sign-up for GAMCO Investors, Inc. Reports Third Quarter Results investment picks
The Board of Trustees of the GAMCO Natural Resources, Gold & Income Trust (NYSE:GNT) (the “Fund”) declared monthly cash distributions of $0.07 per share for each of January, February, and March 2015.
Sign-up for GAMCO Natural Resources, Gold & Income Trust Continues Monthly Distributions, Declaring Distributions of $0.07 Per Share investment picks
2015/1/14
Date Change Allows For Expanded Roll-out in IMAX® Theatres Domestically Beginning at 10 p.m. on Thursday, January 29 SANTA MONICA, Calif.
Sign-up for Game of Thrones® IMAX® Screenings Rescheduled One Week Later To Accommodate Unprecedented Fan Enthusiasm investment picks
2015/1/14
Game of Thrones® IMAX® Screenings Rescheduled One Week Later To Accommodate Unprecedented Fan Enthusiasm Canada NewsWire Date Change Allows For Expanded Roll-out in IMAX® Theatres Domestically Beginning at 10 p.m. on Thursday, January 29 SANTA MONICA, Calif.
Sign-up for Game of Thrones® IMAX® Screenings Rescheduled One Week Later To Accommodate Unprecedented Fan Enthusiasm investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Galena Biopharma Provides 2015 Outlook to Game of Thrones® IMAX® Screenings Rescheduled One Week Later To Accommodate Unprecedented Fan Enthusiasm
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent